Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
暂无分享,去创建一个
Kenjiro Ono | Masahito Yamada | Hironobu Naiki | K. Ono | M. Yamada | K. Hasegawa | H. Naiki | Kazuhiro Hasegawa
[1] George B. Benedek,et al. Kinetic theory of fibrillogenesis of amyloid β-protein , 1997 .
[2] D. Butterfield,et al. Alzheimer's amyloid β-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E , 1999, Neuroscience Letters.
[3] C. Soto,et al. Inhibition of Alzheimer β-Fibrillogenesis by Melatonin* , 1998, The Journal of Biological Chemistry.
[4] N. Altorki,et al. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. , 1999, Carcinogenesis.
[5] G. Cole,et al. Vitamin E protects nerve cells from amyloid beta protein toxicity. , 1992, Biochemical and biophysical research communications.
[6] M. Rao,et al. Nitric Oxide Scavenging by Curcuminoids , 1997, The Journal of pharmacy and pharmacology.
[7] G. Forloni,et al. Anti‐amyloidogenic activity of tetracyclines: studies in vitro , 2001, FEBS letters.
[8] V. Steele,et al. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. , 2000, The Journal of nutrition.
[9] F. Gejyo,et al. Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer's beta-amyloid fibril formation in vitro. , 1997, Biochemistry.
[10] A. Takashima,et al. Nordihydroguaiaretic acid potently breaks down pre‐formed Alzheimer's β‐amyloid fibrils in vitro , 2002, Journal of neurochemistry.
[11] Kenjiro Ono,et al. Nicotine breaks down preformed Alzheimer’s β-amyloid fibrils in vitro , 2002, Biological Psychiatry.
[12] S. DeKosky,et al. Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. , 2000, Archives of neurology.
[13] M. Chan,et al. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. , 1998, Biochemical pharmacology.
[14] Yan Zhou,et al. Actions of Neurotoxic β‐Amyloid on Calcium Homeostasis and Viability of PC12 Cells Are Blocked by Antioxidants but Not by Calcium Channel Antagonists , 1996 .
[15] G. Omenn,et al. Strategy and planning for chemopreventive drug development: Clinical development plans II , 1996, Journal of cellular biochemistry. Supplement.
[16] C. Soto,et al. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. , 1996, Biochemical and biophysical research communications.
[17] J. Hardy,et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. , 2000, Nature.
[18] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[19] S. Martín-Aragón,et al. Modifications on Antioxidant Capacity and Lipid Peroxidation in Mice under Fraxetin Treatment , 1997, The Journal of pharmacy and pharmacology.
[20] So-Young Park,et al. Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from βA(1–42) insult , 2001, Neuroscience Letters.
[21] M. Grundman,et al. Antioxidant strategies for Alzheimer's disease , 2002, Proceedings of the Nutrition Society.
[22] D. Butterfield,et al. The Free Radical Antioxidant Vitamin E Protects Cortical Synaptosomal Membranes from Amyloid β-Peptide(25-35) Toxicity But Not from Hydroxynonenal Toxicity: Relevance to the Free Radical Hypothesis of Alzheimer's Disease , 1998, Neurochemical Research.
[23] L. Fernández-Novoa,et al. Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics. , 2000, Drugs of today.
[24] S. Shimohama,et al. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. , 1997, Annals of neurology.
[25] Ralph A. Nixon,et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease , 2000, Nature.
[26] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[27] P. S. St George-Hyslop,et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. , 2000, Nature.
[28] H. Mori,et al. Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro. , 1994, Biochemical and biophysical research communications.
[29] G. Cole,et al. The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.
[30] M. Smith,et al. Oxidative stress in Alzheimer's disease. , 2000, Biochimica et biophysica acta.
[31] M. Mattson,et al. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation , 1994, Brain Research.
[32] J. Richardson,et al. Actions of neurotoxic beta-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists. , 1996, Journal of neurochemistry.
[33] G. Reaven,et al. Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata). , 1998, European journal of pharmacology.
[34] B Frangione,et al. Inhibition of Alzheimer beta-fibrillogenesis by melatonin. , 1998, The Journal of biological chemistry.
[35] P. Lansbury,et al. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.
[36] R. Motter,et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.
[37] D. Praticò,et al. Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. , 2000, The American journal of medicine.
[38] G. Cole,et al. Vitamin E protects nerve cells from amyloid βprotein toxicity , 1992 .
[39] S. Gautam,et al. Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. , 1997, Hematopathology and molecular hematology.
[40] J. Hardy,et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease , 2000, Nature.
[41] A. Takashima,et al. Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease , 2003, Journal of neurochemistry.
[42] F. Gejyo,et al. Interaction between Aβ (1-42) and Aβ (1-40) in Alzheimer's β-amyloid fibril formation in vitro , 1999 .
[43] T. P. Krishnakantha,et al. Influence of retinol deficiency and curcumin/turmeric feeding on tissue microsomal membrane lipid peroxidation and fatty acids in rats , 1997, Molecular and Cellular Biochemistry.
[44] P. Fraser,et al. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease , 1995, Nature Medicine.
[45] F. Gejyo,et al. Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro. , 1999, Biochemistry.
[46] M. Simmonds,et al. Rosmarinic acid. , 2003, Phytochemistry.
[47] 小野 賢二郎. Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's β-amyloid fibrils in vitro , 2002 .
[48] Kenjiro Ono,et al. Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro. , 2002, Biological psychiatry.
[49] F. Gejyo,et al. Kinetic analysis of amyloid fibril formation. , 1999, Methods in enzymology.
[50] D. Butterfield,et al. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. , 2000, Journal of structural biology.
[51] D. Skovronsky,et al. β-Secretase revealed: starting gate for race to novel therapies for Alzheimer’s disease , 2000 .
[52] H. Naiki,et al. First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[53] V. Menon,et al. Neuroprotective role of curcumin from Curcuma longa on ethanol‐induced brain damage , 1999, Phytotherapy research : PTR.
[54] C. Oliveira,et al. Involvement of Oxidative Stress on the Impairment of Energy Metabolism Induced by Aβ Peptides on PC12 Cells: Protection by Antioxidants , 1999, Neurobiology of Disease.
[55] H. Stähelin,et al. The Relation Between Antioxidants and Memory Performance in the Old and Very Old , 1997, Journal of the American Geriatrics Society.
[56] D. Kirschner,et al. Kinetic theory of fibrillogenesis of amyloid beta-protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[57] D. Skovronsky,et al. Beta-secretase revealed: starting gate for race to novel therapies for Alzheimer's disease. , 2000, Trends in pharmacological sciences.
[58] S. Shimohama,et al. Nicotinic receptor stimulation protects neurons against β‐amyloid toxicity , 1997 .
[59] W. Schaffner,et al. Phytoestrogen kaempferol (3,4′,5,7‐tetrahydroxyflavone) protects PC12 and T47D cells from β‐amyloid–induced toxicity , 1999, Journal of neuroscience research.
[60] G. J. Raymond,et al. Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin , 2003, Journal of Virology.
[61] A. Nunomura,et al. Oxidative Stress, Antioxidants, and Alzheimer Disease , 2000, Alzheimer disease and associated disorders.
[62] A. Hofman,et al. Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. , 1996, American journal of epidemiology.
[63] Kenjiro Ono,et al. Kinetic modeling and determination of reaction constants of Alzheimer's beta-amyloid fibril extension and dissociation using surface plasmon resonance. , 2002, Biochemistry.
[64] F. Gejyo,et al. Apolipoprotein E and antioxidants have different mechanisms of inhibiting Alzheimer's beta-amyloid fibril formation in vitro. , 1998, Biochemistry.
[65] Yongbo Zhang,et al. Nicotine and amyloid formation , 2001, Biological Psychiatry.
[66] S. Asano,et al. Inhibition of Amyloid Protein Aggregation and Neurotoxicity by Rifampicin , 1996, The Journal of Biological Chemistry.